Close
Close
Treatment Database
A small molecule inhibitor of the pro-survival protein Myeloid Cell Leukemia sequence 1 (MCL 1)
Trade Name not avaiable
Orphan Indication Acute Myeloid Leukemia
USA Market Approval
USA Designation Date 15-02-2019
Sponsor Amgen Inc.
One Amgen Center Drive, Mail Stop 27-2-D
Thousand Oaks, California, 91320
More about Acute myeloid leukemia
Free Newsletter
Related Videos